Skyvis Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Delhi, Delhi, India, established in 2022.
2022 Delhi, Delhi, India Active
Last Updated:
Access Report
About Skyvis Pharma Private Limited

Skyvis Pharma Private Limited, a active private limited company, was established on 24 February 2022 in Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100DL2022PTC394292. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.20 M.

Its leadership includes Gaurav Prasher (Director), Siddharth Deshpande (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. Ff-26 First Floor District Centre, Jasola, Delhi, Delhi, 110025.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100DL2022PTC394292

  • Registration Number

    394292

  • Incorporation Date

    24 February 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 3 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Skyvis Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Skyvis Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Skyvis Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Gaurav Prasher Director 24 Feb 2022 Current
Siddharth Deshpande Director 24 Feb 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skyvis Pharma.

Enhance accessibility to Skyvis Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Skyvis Pharma revenue growth over time
Skyvis Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skyvis Pharma?

Unlock access to Skyvis Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skyvis Pharma?

Skyvis Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skyvis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skyvis Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skyvis Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Skyvis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Skyvis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Gaurav Prasher was appointed as a Director was appointed as a Director on 24 Feb 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Siddharth Deshpande was appointed as a Director was appointed as a Director on 24 Feb 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Company Incorporation

    The activity Skyvis Pharma Private Limited was registered on 24 Feb 2022 with Roc Delhi & aged 3 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skyvis Pharma Private Limited?

The CIN of Skyvis Pharma Private Limited is U24100DL2022PTC394292.

Where is Skyvis Pharma Private Limited headquartered?

Skyvis Pharma Private Limited is headquartered at Shop No. Ff-26 First Floor District Centre, Jasola, Delhi, Delhi, 110025.

When was Skyvis Pharma Private Limited incorporated?

Skyvis Pharma Private Limited was incorporated on 24 February 2022.

Who are the current directors of Skyvis Pharma Private Limited?

The current directors of Skyvis Pharma Private Limited are

What is the primary industry of Skyvis Pharma Private Limited?

The primary industry of Skyvis Pharma Private Limited is Chemicals.

Is Skyvis Pharma Private Limited a listed company?

Skyvis Pharma Private Limited is unlisted.

What is the capital structure of Skyvis Pharma Private Limited?

The authorized capital of Skyvis Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available